Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
20/10/2026 06:15
BRIEF-Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026 Oct 20 (Reuters) - Basilea Pharmaceutica AG, Allschwil BSLN.S:
BASILEA REPORTS PRESENTATION OF NEW DATA FOR FOSMANOGEPIX, ISAVUCONAZOLE AND CEFTOBIPROLE AT IDWEEK 2026
Source text: ID:nGNE793V61
Further company coverage: BSLN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Basilea Pharmaceutica AG, Allschwil
See all newsBrief: Basilea Pharmaceutica - Strong Cresemba Sales In Europe Trigger USD 37.5 Mln Milestone Payment
Basilea seen up after raising 2026 guidance
Brief: Basilea Expects 2026 Operating Profit Of CHF 115 Mln
Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments